InvestorsHub Logo
Followers 3
Posts 354
Boards Moderated 0
Alias Born 11/03/2017

Re: zzaatt post# 8309

Friday, 11/17/2017 1:18:59 PM

Friday, November 17, 2017 1:18:59 PM

Post# of 44784
Hello Z.

I agree. I feel for anyone who has been a Pluristem investor for 10 years and is experiencing frustration with this stock. I cannot comment on the price discrepancy between then and now because I don’t know what was going on in the sector back then. As you say, things are never certain in Biotech investments, but when you look back to publications from 2009, the CLI treatment had only just been tested on mice. I have recently read an article that stated that it can take up to 15 years for a new drug/treatment to be developed and get official approval. Due process does take time. The best management in the world can’t circumvent legislative requirements.

Looking at where Pluristem is now just in relation to the CLI treatment, with the Phase III trial being underway and the prospect of a conditional early approval (speculative, I admit) not taking into consideration all the other developments, this company looks very good to me, too. There seems to be an enormous demand for this new treatment method especially by patient groups with very serious health conditions. For their sake alone I hope Pluristem succeed.

I want to end this post with a thought/question because it keeps being mentioned (‘paid pumper’, etc.). Does anybody seriously think that any poster here could exert sufficient influence to manipulate the Pluristem share price with their posts? I am frankly sceptical that this could be done.

Regards,

Bee